Cancer Research
Cancer Research
Comprehensive tools for oncology — from tumor biomarker quantification and apoptosis detection to drug screening and immunotherapy target validation.
Advancing the Fight Against Cancer
Cancer research demands reliable, validated tools across the entire spectrum of investigation — from understanding tumor biology and identifying therapeutic targets to screening drug candidates and monitoring treatment response. Enzo Life Sciences provides oncology researchers with a comprehensive portfolio of ELISA kits for tumor biomarkers, apoptosis and cell death detection assays, SCREEN-WELL libraries for anti-cancer compound screening, and validated antibodies against key oncology targets including PD-L1, HER2, Ki-67, and p53.
Tumor Biomarker Quantification
Sensitive ELISA kits for PSA, CEA, AFP, CA-125, HE4, and other clinically relevant tumor markers. Validated for serum, plasma, and cell culture supernatant analysis with detailed performance data and species cross-reactivity information.
Apoptosis & Cell Death Assays
The most comprehensive cell death detection portfolio in the industry. Annexin V conjugates, caspase activity kits, TUNEL assays, and our proprietary CYTO-ID Autophagy Detection Kit enable multiparameter analysis of tumor cell death mechanisms.
Anti-Cancer Drug Screening
SCREEN-WELL libraries with annotated anti-cancer compounds, kinase inhibitors, and epigenetic modulators. Pre-plated for 96- and 384-well HTS workflows with comprehensive target and mechanism annotations to accelerate hit identification.
Immuno-Oncology Antibodies
Validated antibodies targeting immune checkpoint molecules (PD-1, PD-L1, CTLA-4), tumor-associated antigens, and the tumor microenvironment. Application-verified for IHC, flow cytometry, Western blot, and functional assays.
Cancer Research — By the Numbers
Find tools for your cancer research
Explore our curated product selection for this research area or contact our scientific support team for personalized recommendations.